---
template_id: regulatory-report
template_version: 1.0.0
template_type: base
regulatory_framework: Generic
document_type: report
---

# [DOCUMENT TITLE]

**Document Information**
- Document ID: [AUTO-GENERATED]
- Version: [SEMVER]
- Date: [ISO-DATE]
- Status: [Draft/Review/Approved]

**Device Information**
- Device Name: [DEVICE-NAME]
- Device Model: [DEVICE-MODEL]
- Manufacturer: [MANUFACTURER]
- Device Class: [CLASS]

**Regulatory References**
- [List applicable regulations and standards]
- Example: 21 CFR 820, ISO 13485:2016, ISO 14971:2019

**Approval**
- Author: [NAME] ________ Date: ________
- Reviewer: [NAME] ________ Date: ________
- Approver: [NAME] ________ Date: ________

---

## Executive Summary

*Provide a concise summary (1-2 paragraphs) of the report's purpose, scope, and key conclusions.*

**Purpose**: [State the purpose of this regulatory report]

**Scope**: [Define what is covered and what is excluded]

**Key Findings**: [Summarize the main conclusions]

---

## 1. Introduction

### 1.1 Purpose

*State the specific purpose of this regulatory report.*

### 1.2 Scope

*Define the boundaries of this report: what is included and what is excluded.*

### 1.3 Regulatory Context

*Identify applicable regulatory requirements:*
- FDA regulations (21 CFR)
- EU regulations (MDR 2017/745)
- ISO standards
- Other applicable requirements

### 1.4 Definitions and Abbreviations

| Term | Definition |
|------|------------|
| [TERM] | [DEFINITION] |

---

## 2. Device Description

### 2.1 Device Overview

*Provide a high-level description of the medical device.*

**Device Name**: [DEVICE-NAME]
**Model Number**: [DEVICE-MODEL]
**Intended Use**: [INTENDED-USE-STATEMENT]

### 2.2 Device Components

*List and describe key device components.*

| Component | Description | Material |
|-----------|-------------|----------|
| [COMPONENT-1] | [DESCRIPTION] | [MATERIAL] |
| [COMPONENT-2] | [DESCRIPTION] | [MATERIAL] |

### 2.3 Operating Principle

*Explain how the device works to achieve its intended use.*

---

## 3. Regulatory Assessment

### 3.1 Applicable Regulations

*Identify all applicable regulatory requirements for this device.*

**FDA Requirements**:
- [21 CFR Part/Section]
- [Guidance Document]

**EU Requirements**:
- [MDR Article/Annex]
- [Harmonized Standard]

**ISO Requirements**:
- [ISO Standard:Year]

### 3.2 Compliance Status

*Assess device compliance against applicable regulations.*

| Requirement | Status | Evidence | Gaps |
|-------------|--------|----------|------|
| [REG-001] | [Compliant/Non-compliant/Partial] | [REFERENCE] | [GAP-DESCRIPTION] |

### 3.3 Gap Analysis

*For any non-compliances, describe gaps and remediation plan.*

**Gap**: [GAP-DESCRIPTION]
**Impact**: [IMPACT-ASSESSMENT]
**Remediation Plan**: [PLAN-DESCRIPTION]
**Target Date**: [DATE]
**Owner**: [NAME]

---

## 4. Risk Management Summary

### 4.1 Risk Management Process

*Reference the Risk Management Plan and process followed.*

**Risk Management Plan**: [DOCUMENT-ID]
**Risk Analysis Method**: [FMEA/FTA/Other]
**Risk Acceptability Criteria**: [CRITERIA-REFERENCE]

### 4.2 Key Hazards and Risks

*Summarize the most significant hazards identified.*

| Hazard ID | Hazard Description | Initial Risk | Risk Controls | Residual Risk |
|-----------|-------------------|--------------|---------------|---------------|
| [H-001] | [DESCRIPTION] | [RISK-LEVEL] | [CONTROLS] | [RESIDUAL] |

### 4.3 Overall Risk Assessment

*Provide overall assessment of residual risk acceptability.*

**Overall Residual Risk**: [Acceptable/Not Acceptable]
**Justification**: [RATIONALE per ISO 14971:2019]

---

## 5. Testing and Validation Summary

### 5.1 Verification Testing

*Summarize verification activities (design outputs meet design inputs).*

| Test Protocol | Requirements Verified | Result | Reference |
|---------------|----------------------|--------|-----------|
| [TP-001] | [REQ-001, REQ-002] | [PASS/FAIL] | [TR-001] |

### 5.2 Validation Testing

*Summarize validation activities (device meets user needs and intended use).*

| Validation Activity | Objectives | Result | Reference |
|--------------------|------------|--------|-----------|
| [Clinical Study] | [OBJECTIVES] | [PASS/FAIL] | [REPORT-ID] |

### 5.3 Performance Summary

*Summarize device performance against specifications.*

**Key Performance Metrics**:
- [METRIC-1]: [RESULT] (Specification: [SPEC])
- [METRIC-2]: [RESULT] (Specification: [SPEC])

---

## 6. Clinical Evidence

### 6.1 Clinical Data Sources

*Identify sources of clinical evidence.*

**Literature Review**: [REFERENCE]
**Clinical Investigation**: [STUDY-ID]
**Post-Market Data**: [DATA-SOURCE]

### 6.2 Clinical Performance

*Summarize clinical performance and safety data.*

**Safety Profile**: [SUMMARY]
**Performance Results**: [SUMMARY]
**Benefit-Risk Assessment**: [ASSESSMENT]

---

## 7. Quality Management System

### 7.1 QMS Overview

*Describe the Quality Management System under which the device is manufactured.*

**QMS Standard**: [ISO 13485:2016]
**Certification**: [CERT-NUMBER]
**Certification Body**: [CB-NAME]

### 7.2 Design Control Process

*Summarize design control activities per 21 CFR 820.30.*

| Activity | Reference Document | Status |
|----------|-------------------|--------|
| Design Planning | [PLAN-ID] | [Complete/In-Progress] |
| Design Input | [INPUT-ID] | [Complete/In-Progress] |
| Design Output | [OUTPUT-ID] | [Complete/In-Progress] |
| Design Verification | [VERIF-ID] | [Complete/In-Progress] |
| Design Validation | [VALID-ID] | [Complete/In-Progress] |
| Design Transfer | [TRANSFER-ID] | [Complete/In-Progress] |

---

## 8. Labeling and Instructions for Use

### 8.1 Labeling Compliance

*Assess labeling compliance with applicable requirements.*

**Labeling Requirements**: [21 CFR 801, MDR Annex I Section 23]
**Compliance Status**: [Compliant/Non-compliant]

### 8.2 Instructions for Use

*Reference IFU and assess adequacy.*

**IFU Document**: [IFU-ID]
**Language Versions**: [LIST-LANGUAGES]
**User Testing**: [FORMATIVE/SUMMATIVE-REFERENCE]

---

## 9. Conclusions

### 9.1 Overall Assessment

*Provide overall regulatory assessment conclusion.*

*The [DEVICE-NAME] [meets/does not meet] applicable regulatory requirements for [MARKET].*

### 9.2 Recommendations

*Provide recommendations for regulatory submission or remediation.*

**Recommendation**: [RECOMMENDATION-TEXT]
**Rationale**: [RATIONALE]

### 9.3 Next Steps

*Define next steps in the regulatory pathway.*

1. [ACTION-ITEM-1]
2. [ACTION-ITEM-2]
3. [ACTION-ITEM-3]

---

## 10. References

### 10.1 Regulatory References

*List all regulations, standards, and guidance documents referenced.*

1. [REGULATION/STANDARD, FULL-CITATION]
2. [REGULATION/STANDARD, FULL-CITATION]

### 10.2 Supporting Documents

*List all supporting technical documents referenced.*

| Document ID | Title | Version | Date |
|-------------|-------|---------|------|
| [DOC-ID] | [TITLE] | [VERSION] | [DATE] |

---

## Revision History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| [1.0] | [YYYY-MM-DD] | [NAME] | Initial release |
| [1.1] | [YYYY-MM-DD] | [NAME] | [CHANGE-DESCRIPTION] |

---

**End of Document**

*This document was generated from ARIA template: regulatory-report v1.0.0*
